168 related articles for article (PubMed ID: 17589952)
1. Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.
Chuensumran U; Wongkham S; Pairojkul C; Chauin S; Petmitr S
World J Gastroenterol; 2007 Jun; 13(21):2986-91. PubMed ID: 17589952
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation.
Chuensumran U; Saelee P; Punyarit P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
Asian Pac J Cancer Prev; 2011; 12(3):775-9. PubMed ID: 21627382
[TBL] [Abstract][Full Text] [Related]
3. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.
Muenphon K; Limpaiboon T; Jearanaikoon P; Pairojkul C; Sripa B; Bhudhisawasdi V
World J Gastroenterol; 2006 Jul; 12(26):4143-8. PubMed ID: 16830362
[TBL] [Abstract][Full Text] [Related]
4. Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction.
Chariyalertsak S; Khuhaprema T; Bhudisawasdi V; Sripa B; Wongkham S; Petmitr S
J Cancer Res Clin Oncol; 2005 Dec; 131(12):821-8. PubMed ID: 16180024
[TBL] [Abstract][Full Text] [Related]
5. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.
Thanasai J; Limpaiboon T; Jearanaikoon P; Bhudhisawasdi V; Khuntikeo N; Sripa B; Miwa M
World J Gastroenterol; 2006 Jul; 12(27):4338-44. PubMed ID: 16865775
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.
Limpaiboon T; Tapdara S; Jearanaikoon P; Sripa B; Bhudhisawasdi V
World J Gastroenterol; 2006 Jul; 12(27):4377-82. PubMed ID: 16865781
[TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
8. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint.
Chuensumran U; Saelee P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
Asian Pac J Cancer Prev; 2011; 12(6):1377-80. PubMed ID: 22126467
[TBL] [Abstract][Full Text] [Related]
9. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss in human intrahepatic cholangiocarcinoma: correlation between chromosome 8p22 and tumor progression.
Kawaki J; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Yoshidome H; Uzawa K; Tanzawa H; Nakajima N
Int J Cancer; 2000 Oct; 88(2):228-31. PubMed ID: 11004673
[TBL] [Abstract][Full Text] [Related]
11. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
12. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
[TBL] [Abstract][Full Text] [Related]
13. Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
Xu YP; Dong ZN; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Huang XY; Guo CY
Dig Dis Sci; 2022 Feb; 67(2):559-568. PubMed ID: 33576946
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
Zhang MY; Li SH; Huang GL; Lin GH; Shuang ZY; Lao XM; Xu L; Lin XJ; Wang HY; Li SP
BMC Cancer; 2015 Feb; 15():64. PubMed ID: 25880914
[TBL] [Abstract][Full Text] [Related]
15. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
16. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.
Zhao XQ; Ma HX; Su MS; He L
Int J Clin Exp Pathol; 2014; 7(10):6914-21. PubMed ID: 25400775
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
Zhu YJ; Xu Q; Shao MY; Cao XY; Wu ZR; Chen YW; Bu H; Shi YJ
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):464-470. PubMed ID: 31402267
[TBL] [Abstract][Full Text] [Related]
19. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
20. [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma].
Cong W; Finkelstein SD; Wu M
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):183-7. PubMed ID: 11866974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
